SII clarifies COVID vaccine pricing, says Covishield most affordable vaccine available in market - "The price of the vaccine is still lower than a lot of other medical treatment and essentials required to treat COVID-19," SII said in a statement.
India to send gift of COVID vaccines to Sri Lanka next week
The island nation will get 500,000 doses of the Made in India Covishield vaccine on January 27.
Share
Updated: Jan 23, 2021, 05:55 PM IST
India will be sending a gift of COVID vaccines to Sri Lanka next week. Sri Lankan President Gotabaya Rajapaksa has announced, the vaccine will reach the country on January 27. The island nation will get 500,000 doses of the Made in India Covishield vaccine and it will become the eighth country to which India is gifting COVID vaccines since it began its country-wide mega immunisation programme on January 16.
Starting Wednesday, India has gifted vaccines to seven countries in the region as part of its neighbourhood-first policy Bhutan (150,000), Maldives (100,000), Nepal (One million), Bangladesh (2 million), Myanmar (1.5 M), Seychelles (50,000) and Mauritius (100,000).
Serum Institute CEO Adar Poonawalla takes Covishield jab to endorse its safety and efficacy
Poonawalla s SII, the largest vaccine manufacturer globally, has provided 11 million Covishield doses to the Centre. Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility. (Image Source: Twitter/@narendramodi)
Share
Updated: Jan 16, 2021, 04:22 PM IST
Serum Institute of India’s (SII) CEO Adar Poonawalla on Saturday, joined hundreds of healthcare workers in the country to get the first jab of the COVID-19 vaccine on the inaugural day of the world s biggest inoculation drive. Poonawalla posted a video of him taking the vaccine shot in Pune.
COVID-19: Serum Institute CEO Adar Poonawalla reveals cost of Covishield vaccine in private markets - Check price here Serum Institute of India CEO Adar Poonawalla on Tuesday (January 12) said that Covishield will be made available in private markets at Rs 1,000. Serum Institute of India CEO Adar Poonawalla
Share
Updated: Jan 12, 2021, 09:21 PM IST
In a major announcement, Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday (January 12) said that Covishield will be made available in private markets at Rs 1,000 after getting requisite permission from the Indian government. Poonawalla made the statement at a time when SII has started delivering batches of its COVID-19 vaccine across India.